ImmunityBio, Inc. IBRX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $205.19M+132% | $88.33M+46.6% | $60.24M-56.2% | $137.66M+127% | $60.66M-57.7% | ||
| $175.69M+13.7% | $154.48M-21.8% | $197.57M+1,135% | $16M+1,619% | $931K-85.4% | ||
| $139.98M+23.1% | $113.74M+54.7% | $73.53M+60.9% | $45.69M+85.8% | $24.6M+225% | ||
| $45.71M+29.5% | $35.3M+62.0% | $21.79M+27.8% | $17.04M+39.5% | $12.21M+224% | ||
| $452.95M+43.9% | $314.88M-4.4% | $329.5M+58.3% | $208.13M+90.7% | $109.16M-40.9% | ||
| $112.79M-1.3% | $114.26M-11.8% | $129.6M-2.6% | $133M-1.7% | $135.27M-1.3% | ||
| $910K0.0% | $910K0.0% | $910K0.0% | $910K— | —— | ||
| $11.91M-8.3% | $12.99M— | —— | —— | —— | ||
| $646.64M+28.8% | $501.9M-3.3% | $518.99M+29.1% | $402.08M+32.4% | $303.76M-20.7% | ||
| $53K— | —— | —— | —— | —— | ||
| $67.95M+10.0% | $61.75M+8.1% | $57.13M+12.8% | $50.64M+2.9% | $49.21M-10.4% | ||
| $404.3M+24.5% | $324.62M+2.7% | $316.15M+3.0% | $307.05M+3.6% | $296.29M+4.2% | ||
| $1.52B+51.4% | $1B-3.9% | $1.04B+7.3% | $971.9M+8.7% | $894.24M+2.7% | ||
| 1.7B0.0% | 1.7B+22.2% | 1.4B0.0% | 1.4B0.0% | 1.4B+1,588,135% | ||
| -$4.36B-17.0% | -$3.73B-1.7% | -$3.66B-1.9% | -$3.6B-2.6% | -$3.5B-3.8% | ||
| -$870.01M-73.8% | -$500.47M+4.5% | -$524.32M+8.1% | -$570.75M+3.5% | -$591.43M-20.9% | ||
| $646.64M+28.8% | $501.9M-3.3% | $518.99M+29.1% | $402.08M+32.4% | $303.76M-20.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are ImmunityBio, Inc.'s total assets?
- ImmunityBio, Inc. (IBRX) holds $646.6M in total assets, up 112.9% year over year.
- How much debt does ImmunityBio, Inc. have?
- ImmunityBio, Inc. carries $445.4M in total debt against -$870.0M of shareholders' equity, a debt-to-equity ratio of 0.11.
- How much cash does ImmunityBio, Inc. have?
- ImmunityBio, Inc. holds $205.2M in cash and equivalents.
- Can ImmunityBio, Inc. cover its short-term obligations?
- Its current ratio is 6.67 — current assets exceed current liabilities.
- Where does ImmunityBio, Inc.'s balance sheet data come from?
- Every line is extracted from ImmunityBio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
